Archives20242023202220212020201920182017201620152014201320122011 June 02, 2020Notification of Change of AGM Venue Read More May 21, 2020Notice of AGM and posting of Report & Accounts Read More May 18, 2020TR1 – Notification of major interest in shares by Lanstead Capital Read More May 14, 2020ImmuPharma’s efforts in the fight against Covid-19 with Lupuzor™ and Ureka Read More April 30, 2020Audited Report & Accounts published on website Read More April 30, 2020FINAL RESULTS For the 12 months ended 31 December 2019 Read More April 06, 2020ImmuPharma to present live on ‘Investor Meet Company’ platform Tuesday 7 April 2020 | 10.30am (BST) Read More April 03, 2020TR1 – Notification of major interest in shares by Lanstead Capital – 3 April 2020 Read More April 03, 2020TR1 – Notification of major interest in shares from Robert Zimmer – 2 April 2020 Read More March 30, 2020Subscription to raise £1.5 million to fund expansion of R&D pipeline Read More February 28, 2020Incanthera plc – Admission to trading on the NEX Exchange Growth Market Publication of Admission Document Read More February 17, 2020Oncology specialist Incanthera, in which ImmuPharma currently has a 14.0% shareholding, announces Rule 23 Notice in advance to quoting on NEX Exchange Growth Market Read More 1…7891011…14
April 06, 2020ImmuPharma to present live on ‘Investor Meet Company’ platform Tuesday 7 April 2020 | 10.30am (BST) Read More
April 03, 2020TR1 – Notification of major interest in shares by Lanstead Capital – 3 April 2020 Read More
April 03, 2020TR1 – Notification of major interest in shares from Robert Zimmer – 2 April 2020 Read More
February 28, 2020Incanthera plc – Admission to trading on the NEX Exchange Growth Market Publication of Admission Document Read More
February 17, 2020Oncology specialist Incanthera, in which ImmuPharma currently has a 14.0% shareholding, announces Rule 23 Notice in advance to quoting on NEX Exchange Growth Market Read More